2017 Information
What is SimWARS™?
SimWARS™ is double-elimination competition that challenges clinical
interdisciplinary healthcare teams to compete against each other in simulated
patient scenarios.
Is there an audience?
The preliminary rounds are conducted in the Simulation Center at Saint
Barnabas with independent judges determining the winning teams. Northeastern States are encouraged to send teams to represent their state. The final round will be held in the Islami Auditorium in front of an audience.
Are we judged?
Each team’s performance will be reviewed by an expert panel examining
the areas of teamwork, communication, and clinical decision making. The
champions will be determined through a combination of audience voting,
using an audience response system and the judges scoring.
How is the competition organized?
Round 1 (September 17 to 23, 2017)
Teams will compete against each other in the management of a simulated
case. Team A will compete against Team B in round 1, blinded to each other’s
performance. Team C will do the same against Team D and so on. Expert
judges will give their input and winners will be determined. The winning
teams will advance to the next round. Losing teams will be reconfigured
to form new “scrambled” teams who will then compete.
Finals – Thursday, November 2, 2017
The finalist from the preliminary round will compete for the title of the
2017 Northeastern Interprofessional SimWARS™ Champion.
Is there a fee?
There is no fee to participate in SimWARS™
Do we have to be familiar with simulation?
No, no previous experience with simulation in necessary.
Do we have to be familiar with emergency procedures?
No, oral and maxillofacial surgeons have participated in cases.
Where has SimWARS™ been held previously?
SimWARS™ is held yearly at the International Meeting for Simulation
in Healthcare (IMSH), the American College of Emergency Physicians (ACEP)
Academic Assemble, Saint Barnabas Medical Center and at many venues around
the world.
Who created SimWARS™?
The SimWARS™ competition was developed by: Haru Okuda, MD, Andy
Godwin, MD and Scott Weingart, MD